Shukla Sath (CIK 1782817) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-05). Recent activity: Buy SPRO (751,407 shares), Sell SPRO (6,139 shares), Sell SPRO (42,786 shares), Sell SPRO (106,408 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-05 | Spero Therapeutics, Inc. (SPRO) | CEO & President | Buy | 751,407 | $0 |
| 2025-02-05 | Spero Therapeutics, Inc. (SPRO) | CEO & President | Sell | 6,139 | $4,788 |
| 2025-02-05 | Spero Therapeutics, Inc. (SPRO) | CEO & President | Sell | 42,786 | $33,373 |
| 2025-02-05 | Spero Therapeutics, Inc. (SPRO) | CEO & President | Sell | 106,408 | $82,998 |
Source: SEC Form 4 filings · as of 2025-02-05